Rosanna Leuzzi

Rosanna Leuzzi

Auto-generated profile, based on publicly available information

Rosanna Leuzzi

Siena

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
GGGianmarco Gasperini
Gianmarco Gasperini
MBMassimiliano Biagini
Massimiliano Biagini
VAVanessa Arato
Vanessa Arato
CGClaudia Gianfaldoni
Claudia Gianfaldoni
AVAlessandro Vadi
Alessandro Vadi
RLRosanna Leuzzi
Rosanna Leuzzi
Despite high vaccination coverage world-wide, whooping cough, a highly contagious disease caused by Bordetella pertussis, is recently increasing in occurrence suggesting that novel vaccine formulations targeted at the prevention of colonization and transmission should be investigated. To identify new candidates for inclusion in the acellular formulation, we used spontaneously released outer membrane vesicles (OMV)1 as a potential source of key adhesins. The enrichment of Bvg+ OMV with adhesins and the ability of anti-OMV serum to inhibit the adhesion of B. pertussis to lung epithelial cells in vitro were demonstrated. We employed a proteomic approach to identify the differentially expressed proteins in OMV purified from bacteria in the Bvg+ and Bvg− virulence phases, thus comparing the outer membrane protein pattern of this pathogen in its virulent or avirulent state. Six of the most abundant outer membrane proteins were selected as candidates to be evaluated for their adhesive properties and vaccine potential. We generated E. coli strains singularly expressing the selected proteins and assessed their ability to adhere to lung epithelial cells in vitro. Four out of the selected proteins conferred adhesive ability to E. coli. Three of the candidates were specifically detected by anti-OMV mouse serum suggesting that these proteins are immunogenic antigens able to elicit an antibody response when displayed on the OMV. Anti-OMV serum was able to inhibit only BrkA-expressing E. coli adhesion to lung epithelial cells. Finally, stand-alone immunization of mice with recombinant BrkA resulted in significant protection against infection of the lower respiratory tract after challenge with B. pertussis. Taken together, these data support the inclusion of BrkA and possibly further adhesins to the current acellular pertussis vaccines to improve the impact of vaccination on the bacterial clearance.

3 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VAVanessa Arato
Vanessa Arato
GGGianmarco Gasperini
Gianmarco Gasperini
FGFabiola Giusti
Fabiola Giusti
IFIlaria Ferlenghi
Ilaria Ferlenghi
MSMaria Scarselli
Maria Scarselli
RLRosanna Leuzzi
Rosanna Leuzzi
Clostridium difficileis a Gram-positive, anaerobic bacterium and the leading cause of antibiotic-associated diarrhea and pseudomembranous colitis.C. difficilemodulates its transition from a motile to a sessile lifestyle through a mechanism of riboswitches regulated by cyclic diguanosine monophosphate (c-di-GMP). Previously described as a sortase substrate positively regulated by c-di-GMP, CD2831 was predicted to be a collagen-binding protein and thus potentially involved in sessility. By overexpressing CD2831 inC. difficileand heterologously expressing it on the surface ofLactococcus lactis, here we further demonstrated that CD2831 is a collagen-binding protein, able to bind to immobilized collagen types I, III and V as well as native collagen produced by human fibroblasts. We also observed that the overexpression of CD2831 raises the ability to form biofilm on abiotic surface in bothC. difficileandL. lactis. Notably, we showed that CD2831 binds to the collagen-like domain of the human complement component C1q, suggesting a role in preventing complement cascade activation via the classical pathway. This functional characterization places CD2831 in theMicrobialSurfaceComponentsRecognizingAdhesiveMatrixMolecule (MSCRAMMs) family, a class of virulence factors with a dual role in adhesion to collagen-rich tissues and in host immune evasion by binding to human complement components.

1 August 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
VAValentina Agnolon
Valentina Agnolon
CBCristina Bruno
Cristina Bruno
RLRosanna Leuzzi
Rosanna Leuzzi
BGBruno Galletti
Bruno Galletti
UDUgo D'Oro
Ugo D'Oro
BBBarbara C. Baudner
Barbara C. Baudner

8 November 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
RLRosanna Leuzzi
Rosanna Leuzzi
MBMargherita Bodini
Margherita Bodini
ITIsaac P. Thomsen
Isaac P. Thomsen
ESElisabetta Soldaini
Elisabetta Soldaini
EBErika Bartolini
Erika Bartolini
CCClarence B. Creech
Clarence B. Creech
Staphylococcus aureus is a common human commensal and the leading cause of diverse infections. To identify distinctive parameters associated with infection and colonization, we compared the immune and inflammatory responses of patients with a diagnosis of invasive S. aureus disease to healthy donors. We analyzed the inflammatory responses founding a pattern of distinctive cytokines significantly higher in the patients with invasive disease. The measure of antibody levels revealed a wide antibody responsiveness from all subjects to most of the antigens, with significantly higher response for some antigens in the invasive patients compared to control. Moreover, functional antibodies against toxins distinctively associated with the invasive disease. Finally, we examined the genomic variability of isolates, showing no major differences in genetic distribution compared to a panel of representative strains. Overall, our study shows specific signatures of cytokines and functional antibodies in patients with different primary invasive diseases caused by S. aureus. These data provide insight into human responses towards invasive staphylococcal infections and are important for guiding the identification of novel preventive and therapeutic interventions against S. aureus.

5 October 2017 in Future Microbiology
Verified
Journal Article
Closed access
GGGianmarco Gasperini
Gianmarco Gasperini
VAVanessa Arato
Vanessa Arato
MPMariagrazia Pizza
Mariagrazia Pizza
BABeatrice Aricò
Beatrice Aricò
RLRosanna Leuzzi
Rosanna Leuzzi
Aim: Bordetella pertussis has been shown to release outer membrane vesicles (OMV) both in vitro and in vivo but little is known about their biological role during the initial phases of B. pertussis infection of the airways. Results: We have demonstrated that OMV are released by B. pertussis in a human ciliated-airway cell model and purified vesicles can interact with host cells. Binding and uptake are strictly Bvg-regulated and OMV-associated pertussis toxin contributes to host-cell intoxication. Furthermore, we have shown that OMV act as iron-delivery systems complementing the B. pertussis growth defect in iron-limiting conditions. Conclusion: We have proved that OMV play different roles in B. pertussis physiopathology and we opened new perspectives to be further investigated.

15 September 2016 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
EZElisa Zanaboni
Elisa Zanaboni
VAVanessa Arato
Vanessa Arato
MPMariagrazia Pizza
Mariagrazia Pizza
ASAnja Seubert
Anja Seubert
RLRosanna Leuzzi
Rosanna Leuzzi
Pertussis or whooping cough is an acute respiratory illness caused by the Gram-negative pathogen Bordetella pertussis. Despite high vaccination coverage whooping cough is currently re-emerging in many developed countries. Although the causes of pertussis resurgence are matter of debate, emerging evidences suggest that acellular vaccines efficiently protect against the hallmark symptoms of pertussis disease but fail to prevent colonization. This presumably impacts on increased risk of bacterial transmission and consequent spread throughout the population. These evidences suggest that improved vaccines may be required for efficient bacterial clearance in the upper respiratory tract. Consequently, there is a need for novel bioassays to evaluate at pre-clinical or clinical level the impact of different vaccines on B. pertussis colonization. We developed a high-throughput bacterial adhesion inhibition (BAI) assay based on human respiratory cell lines and on live bacteria chemically conjugated to a fluorescent dye. Employing A549 cells as model, we evaluated the impact of antibodies elicited by acellular (aP) and whole cell (wP) vaccines on B. pertussis adhesion in vitro. Moreover, we settled the method also on polarized Calu-3 cells grown at air-liquid interface (ALI), showing that this assay can be extended to more complex cell models mimicking the airway epithelium. We proved that this method is a sensitive, rapid and reproducible system to evaluate the anti-adhesive properties of vaccine-induced antibodies and can be employed to assess improved pertussis vaccines.